[go: up one dir, main page]

Follow
Bradford Hirsch
Bradford Hirsch
CEO, SignalPath Research
Verified email at signalpath.com - Homepage
Title
Cited by
Cited by
Year
Delivering affordable cancer care in high-income countries
R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ...
The Lancet Oncology 12 (10), 933-980, 2011
8662011
Surgical prehabilitation in patients with cancer: state-of-the-science and recommendations for future research from a panel of subject matter experts
F Carli, JK Silver, LS Feldman, A McKee, S Gilman, C Gillis, ...
Physical Medicine and Rehabilitation Clinics 28 (1), 49-64, 2017
2702017
Characteristics of Oncology Clinical Trials: Insights From a Systematic Analysis of ClinicalTrials. gov.
BR Hirsch, RM Califf, SK Cheng, A Tasneem, J Horton, K Chiswell, ...
JAMA internal medicine, 1-8, 2013
262*2013
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors
JF Cryan, OF O'Leary, SH Jin, JC Friedland, M Ouyang, BR Hirsch, ...
Proceedings of the National Academy of Sciences 101 (21), 8186-8191, 2004
2402004
Capecitabine in the management of colorectal cancer
BR Hirsch, SY Zafar
Cancer management and research, 79-89, 2011
1282011
Use of dopamine-β-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs
JF Cryan, A Dalvi, SH Jin, BR Hirsch, I Lucki, SA Thomas
The Journal of pharmacology and experimental therapeutics 298 (2), 651-657, 2001
1142001
Relationship between cancer and cardiovascular outcomes following percutaneous coronary intervention
CN Hess, MT Roe, RM Clare, K Chiswell, J Kelly, JE Tcheng, E Hagstrom, ...
Journal of the American Heart Association 4 (7), e001779, 2015
892015
Clinical trial participants with metastatic renal cell carcinoma differ from patients treated in real-world practice
AP Mitchell, MR Harrison, MS Walker, DJ George, AP Abernethy, ...
Journal of oncology practice 11 (6), 491-497, 2015
882015
The impact of specialty pharmaceuticals as drivers of health care costs
BR Hirsch, S Balu, KA Schulman
Health Affairs 33 (10), 1714-1720, 2014
852014
Assessing the value of patient-generated data to comparative effectiveness research
L Howie, B Hirsch, T Locklear, AP Abernethy
Health Affairs 33 (7), 1220-1228, 2014
842014
Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009
MA Dinan, X Mi, SD Reed, BR Hirsch, GH Lyman, LH Curtis
JAMA Oncology, 2015
742015
Management of chemotherapy-induced neutropenia: measuring quality, cost, and value
MA Dinan, BR Hirsch, GH Lyman
Journal of the National Comprehensive Cancer Network 13 (1), e1-e7, 2015
682015
Response rate as a regulatory end point in single-arm studies of advanced solid tumors
GR Oxnard, KH Wilcox, M Gonen, M Polotsky, BR Hirsch, LH Schwartz
JAMA oncology 2 (6), 772-779, 2016
622016
Biosimilars: are they ready for primetime in the United States?
BR Hirsch, GH Lyman
Journal of the National Comprehensive Cancer Network 9 (8), 934-943, 2011
462011
Breast cancer screening with mammography
BR Hirsch, GH Lyman
Current Oncology Reports 13 (1), 63-70, 2011
382011
Biosimilars: a cure to the US health care cost conundrum?
BR Hirsch, GH Lyman
Blood Reviews 28 (6), 263-268, 2014
332014
Pharmacoeconomics of the myeloid growth factors: a critical and systematic review
BR Hirsch, GH Lyman
Pharmacoeconomics 30 (6), 497-511, 2012
332012
Real-world outcomes in metastatic renal cell carcinoma: insights from a Joint Community-Academic Registry
MR Harrison, BR Hirsch, DJ George, MS Walker, C Chen, B Korytowsky, ...
Journal of oncology practice 10 (2), e63-e72, 2014
322014
Will biosimilars gain momentum?
BR Hirsch, GH Lyman
Journal of the National Comprehensive Cancer Network 11 (10), 1291-1297, 2013
292013
A comparison of FDA and EMA drug approval: implications for drug development and cost of care.
LJ Howie, BR Hirsch, AP Abernethy
Oncology (08909091) 27 (12), 2013
262013
The system can't perform the operation now. Try again later.
Articles 1–20